diclofenac
diclofenac: developed by 1 company · 2 clinical trials tracked · 1 FDA decision.
diclofenac evidence translation
What we can confirm
1 FDA record · 2 tracked trials
What it means
What to watch
Prepared research question
How could diclofenac → ZCOR affect its developer, and what evidence supports the link?
Traceable citations · Unknowns marked
See linked entities and source evidence3 indications · 2 study sponsors
Related indications
Development Pipeline (1)
| Company | Phase |
|---|---|
| Zyla Life Sciences (ZCOR) mild to moderate acute pain and osteoarthritis pain | Approved |
Clinical Trials (2)
A Randomized Controlled Trial: Alternative Post Procedural Analgesia With NSAIDs vs Opioids in Percutaneous Needle Tenotomy of Elbow
Primary endpoint: Number of pills taken
A Study to Evaluate the Clinical Benefits of Tramadol/Acetaminophen (Ultracet®) vs. Diclofenac (Voltaren®) in the Treatment of Pain in Patients With Ankylosing Spondylitis Receiving Stable Treatment of Disease Modifying Anti-rheumatic Drugs (DMARDs)
Primary endpoint: Change From Baseline in Visual Analogue Scale (VAS) Score at Week 2
Frequently asked questions
Who is developing diclofenac?
diclofenac is being developed by Zyla Life Sciences.
How many clinical trials involve diclofenac?
BioSniper tracks 2 clinical trials involving diclofenac.
What is diclofenac's latest FDA decision?
The most recent tracked FDA decision for diclofenac is Approval, dated October 18, 2013.